Advertisement
Letter to the Editor| Volume 78, P154-156, August 2020

Comparative prediction of long-term mortality by the CHA2DS2-VASc score and cardiac troponin I levels in patients with atrial fibrillation at the emergency department

Published:April 14, 2020DOI:https://doi.org/10.1016/j.ejim.2020.04.021
Comparative prediction of long-term mortality by the CHA2DS2-VASc score and cardiac troponin I levels in patients with atrial fibrillation at the emergency department
Previous ArticleWhy the four non-vitamin K-antagonist oral anticoagulants are actually five
Next ArticleThe Impact Of Diabetes Mellitus And Microvascular Complications On Heart Failure Biomarkers
      Atrial fibrillation (AF) is the most common arrhythmia in clinical practice, and is associated with an increased risk of stroke, heart failure (HF) and mortality [
      • Schnabel R.B.
      • Yin X.
      • Gona P.
      • Larson M.G.
      • Beiser A.S.
      • McManus D.D.
      • et al.
      50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study.
      Lancet. 2015; 386: 154-162
      https://doi.org/10.1016/S0140-6736(14)61774-8
      ]. In this regard, the CHA2DS2-VASc score is a well-known predictor of stroke in patients with AF, with some studies evaluating its use as a marker for predicting all-cause death [
      • Crandall M.A.
      • Horne B.D.
      • Day J.D.
      • Anderson J.L.
      • Muhlestein J.B.
      • Crandall B.G.
      • et al.
      Atrial fibrillation significantly increases total mortality and stroke risk beyond that conveyed by the CHADS2 risk factors.
      Pacing Clin Electrophysiol. 2009; 32: 981-986
      https://doi.org/10.1111/j.1540-8159.2009.02427.x
      ,
      • Ntaios G.
      • Lip G.Y.H.
      • Makaritsis K.
      • Papavasileiou V.
      • Vemmou A.
      • Koroboki E.
      • et al.
      CHADS2, CHA2S2DS2-VASc, and long-term stroke outcome in patients without atrial fibrillation.
      Neurology. 2013; 80: 1009-1017
      https://doi.org/10.1212/WNL.0b013e318287281b
      . Cardiac troponin I (cTnI) has consistently provided prognostic information on the risk of stroke, vascular events and mortality in patients with AF [
      • Hijazi Z.
      • Oldgren J.
      • Andersson U.
      • Connolly S.J.
      • Ezekowitz M.D.
      • Hohnloser S.H.
      • et al.
      Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a randomized evaluation of long-term anticoagulation therapy (RE-LY) substudy.
      Circulation. 2012; 125: 1605-1616
      https://doi.org/10.1161/CIRCULATIONAHA.111.038729
      ]. However, it is not known whether the prognostic value of cTnI prevails or is better than the CHA2DS2-VASc score in patients attending the emergency department (ED) for a variety of reasons, but having documented AF on the admission electrocardiogram (ECG). Therefore, our study sought to determine the prognostic value of cTnI and the CHA2DS2-VASc score in predicting a 5-year all-cause mortality and readmission for HF or myocardial infarction (MI) in a cohort of unselected AF patients, attending the ED.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Schnabel R.B.
        • Yin X.
        • Gona P.
        • Larson M.G.
        • Beiser A.S.
        • McManus D.D.
        • et al.
        50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study.
        Lancet. 2015; 386: 154-162
        https://doi.org/10.1016/S0140-6736(14)61774-8
        View in Article
        • Crandall M.A.
        • Horne B.D.
        • Day J.D.
        • Anderson J.L.
        • Muhlestein J.B.
        • Crandall B.G.
        • et al.
        Atrial fibrillation significantly increases total mortality and stroke risk beyond that conveyed by the CHADS2 risk factors.
        Pacing Clin Electrophysiol. 2009; 32: 981-986
        https://doi.org/10.1111/j.1540-8159.2009.02427.x
        View in Article
        • Ntaios G.
        • Lip G.Y.H.
        • Makaritsis K.
        • Papavasileiou V.
        • Vemmou A.
        • Koroboki E.
        • et al.
        CHADS2, CHA2S2DS2-VASc, and long-term stroke outcome in patients without atrial fibrillation.
        Neurology. 2013; 80: 1009-1017
        https://doi.org/10.1212/WNL.0b013e318287281b
        View in Article
        • Hijazi Z.
        • Oldgren J.
        • Andersson U.
        • Connolly S.J.
        • Ezekowitz M.D.
        • Hohnloser S.H.
        • et al.
        Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a randomized evaluation of long-term anticoagulation therapy (RE-LY) substudy.
        Circulation. 2012; 125: 1605-1616
        https://doi.org/10.1161/CIRCULATIONAHA.111.038729
        View in Article
        • Parwani A.S.
        • Boldt L.H.
        • Huemer M.
        • Wutzler A.
        • Blaschke D.
        • Rolf S.
        • et al.
        Atrial fibrillation-induced cardiac troponin I release.
        Int J Cardiol. 2013; 168: 2734-2737
        https://doi.org/10.1016/j.ijcard.2013.03.087
        View in Article
        • Naffaa M.E.
        • Nasser R.
        • Manassa E.
        • Younis M.
        • Azzam Z.S.
        • Aronson D
        Cardiac troponin-I as a predictor of mortality in patients with first episode acute atrial fibrillation.
        QJM. 2017; 110: 507-511
        https://doi.org/10.1093/qjmed/hcx060
        View in Article
        • Stoyanov K.M.
        • Giannitsis E.
        • Biener M.
        • Mueller-Hennessen M.
        • Arens K.
        • Katus H.A.
        • et al.
        Prognostic value of elevated high-sensitivity cardiac troponin T in patients admitted to an emergency department with atrial fibrillation.
        Europace. 2018; 20: 582-588
        https://doi.org/10.1093/europace/eux063
        View in Article
        • Rozenbaum Z.
        • Elis A.
        • Shuvy M.
        • Vorobeichik D.
        • Shlomo N.
        • Shlezinger M.
        • et al.
        CHA2DS2-VASc score and clinical outcomes of patients with acute coronary syndrome.
        Eur J Intern Med. 2016; 36: 57-61
        https://doi.org/10.1016/j.ejim.2016.09.010
        View in Article
        • Mitchell L.B.
        • Southern D.A.
        • Galbraith D.
        • Ghali W.A.
        • Knudtson M.
        • Wilton S.B
        Prediction of stroke or TIA in patients without atrial fibrillation using CHADS2 and CHA2DS2-VASc scores.
        Heart. 2014; 100: 1524-1530
        https://doi.org/10.1136/heartjnl-2013-305303
        View in Article

      Article info

      Publication history

      Published online: April 14, 2020
      Accepted: April 6, 2020
      Received in revised form: March 28, 2020
      Received: January 21, 2020

      Identification

      DOI: https://doi.org/10.1016/j.ejim.2020.04.021

      Copyright

      © 2020 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX